Giannotti B - Search Results

1

Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.

Bajetta E, Di Leo A, Zampino MG, Sertoli MR, Comella G, Barduagni M, Giannotti B, Queirolo P, Tribbia G, Bernengo MG, et al. Bajetta E, et al. Among authors: giannotti b. J Clin Oncol. 1994 Apr;12(4):806-11. doi: 10.1200/JCO.1994.12.4.806. J Clin Oncol. 1994. PMID: 8151323 Clinical Trial.

2

Phase II study of interferon alpha-2a and dacarbazine in advanced melanoma.

Bajetta E, Negretti E, Giannotti B, Brogelli L, Brunetti I, Sertoli MR, Bernengo MG, Sofra MC, Maifredi G, Zumiani G, et al. Bajetta E, et al. Among authors: giannotti b. Am J Clin Oncol. 1990 Oct;13(5):405-9. doi: 10.1097/00000421-199010000-00008. Am J Clin Oncol. 1990. PMID: 2220660 Clinical Trial.

3

Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions.

Moretti S, Massobrio R, Brogelli L, Novelli M, Giannotti B, Bernengo MG. Moretti S, et al. Among authors: giannotti b. J Invest Dermatol. 1990 Sep;95(3):320-4. doi: 10.1111/1523-1747.ep12485060. J Invest Dermatol. 1990. PMID: 1696603 Free article.

4

Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cells.

Prignano F, Coronnello M, Pimpinelli N, Cappugi P, Mini E, Giannotti B. Prignano F, et al. Among authors: giannotti b. Cancer Lett. 2002 Dec 5;186(2):183-92. doi: 10.1016/s0304-3835(02)00343-9. Cancer Lett. 2002. PMID: 12213288

5

Superficial spreading melanoma with a nodular area: antigenic phenotype of the radial and vertical growth areas.

Brogelli L, Moretti S, Giannotti B. Brogelli L, et al. Among authors: giannotti b. Tumori. 1989 Feb 28;75(1):8-11. doi: 10.1177/030089168907500103. Tumori. 1989. PMID: 2711482

6

HLA-DR and 96-K antigens and intratumoral lymphocytic infiltrate in primary cutaneous melanoma as markers of tumor progression.

Brogelli L, Moretti S, Borgognoni L, Giannotti B. Brogelli L, et al. Among authors: giannotti b. Dermatologica. 1990;180(2):69-72. doi: 10.1159/000247993. Dermatologica. 1990. PMID: 2311798

7

Non-lymphoid accessory cells in the cutaneous infiltrate of B cell lymphomas. An immunohistochemical and ultrastructural study.

Pimpinelli N, Romagnoli P, Moretti S, Giannotti B. Pimpinelli N, et al. Among authors: giannotti b. Br J Dermatol. 1988 Mar;118(3):353-62. doi: 10.1111/j.1365-2133.1988.tb02428.x. Br J Dermatol. 1988. PMID: 3258525

8

Adhesion molecule profile and malignancy of melanocytic lesions.

Moretti S, Martini L, Berti E, Pinzi C, Giannotti B. Moretti S, et al. Among authors: giannotti b. Melanoma Res. 1993 Aug;3(4):235-9. Melanoma Res. 1993. PMID: 8219755

9

In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expression.

Moretti S, Pinzi C, Berti E, Spallanzani A, Chiarugi A, Boddi V, Reali UM, Giannotti B. Moretti S, et al. Among authors: giannotti b. Melanoma Res. 1997 Aug;7(4):313-21. doi: 10.1097/00008390-199708000-00006. Melanoma Res. 1997. PMID: 9293481

10

Melanocytic naevi: clinical features and correlation with the phenotype in healthy young males in Italy.

Brogelli L, De Giorgi V, Bini F, Giannotti B. Brogelli L, et al. Among authors: giannotti b. Br J Dermatol. 1991 Oct;125(4):349-52. doi: 10.1111/j.1365-2133.1991.tb14170.x. Br J Dermatol. 1991. PMID: 1954124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page